Independent directory Public ClinicalTrials.gov records United States
Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–53 of 53 matching trials from the live ClinicalTrials.gov search.
Conditions
Infertility
Interventions
Bravelle(follicle stimulating hormone), Saline ( placebo)
Drug · Other
Lead sponsor
University of California, San Francisco
Other
Eligibility
18 Years and older · Female only
Enrollment
232 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2010
U.S. locations
1
States / cities
San Francisco, California
Conditions
Medical Abortion
Interventions
serum BhCG follow-up, ultrasonographic follow-up
Other
Lead sponsor
Planned Parenthood League of Massachusetts
Other
Eligibility
18 Years to 64 Years · Female only
Enrollment
376 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2010
U.S. locations
1
States / cities
Boston, Massachusetts
Active, not recruiting No phase listed Observational

Assessment of Early Pregnancy MAB Completion

NCT06893484
Conditions
Pregnancy, Abortion Early
Interventions
Weekly high-sensitivity urine pregnancy tests
Diagnostic Test
Lead sponsor
University of Washington
Other
Eligibility
Female only
Enrollment
400 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
3
States / cities
Atlanta, Georgia • Chevy Chase, Maryland • Renton, Washington
Conditions
Oligospermia, Azoospermia, Nonobstructive, Infertility
Interventions
isotretinoin, Human chorionic gonadotrophin (hCG)
Drug
Lead sponsor
University of Nebraska
Other
Eligibility
19 Years to 50 Years · Male only
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
1
States / cities
Omaha, Nebraska
Completed No phase listed Observational

Sofia hCG FIA Field Study

NCT01803113
Conditions
Pregnancy, Early Detection
Interventions
Sofia hCG FIA
Device
Lead sponsor
Quidel Corporation
Industry
Eligibility
Female only
Enrollment
975 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013
U.S. locations
5
States / cities
Boynton Beach, Florida • Fall River, Massachusetts • Pawtucket, Rhode Island + 1 more